Bio-Modeling Systems is founded
by Dr. Iris, M. Gea and Dr. Dine
Participation in 2 French nation-wide projects; profitable ever since
Development of the CADI™ analytical platform.
Four new models completed (FGF4-driven fibroblast differentiation, hypercholesterolemia, Chronic Fatigue Syndrome, Creutzfeldt Jakob disease) two of which are undergoing independent biological evaluation.
Synthons White Biotechnology
Bio-Defense and Bio-Security
Invention of 3 proprietary technologies
TAPE, RipH, AbACCUS
allowing the production of phage banks capable of targeting any known or yet unknown bacteria
Patent covering new therapeutic strategies and creation of a preclinical evaluation platform in the field of psychiatric disorders.
Pherecydes Pharma S.A. spin-off (anti-bacterial bio-agents) incorporation
- Bio-IT World Best Practices Award from the Cambridge Healthtech Institute
- State-of-the-Art of Systems Biology applications in Medicine award; European Commission DG 2010
Computational Biophysics of the Skin book publication
CEA /BMSystems collaborative research in CNS (Psychiatric and Neurological disorders) led to the co-owned patent WO201029131 with a worldwide exclusive license to Theranexus CEA’s spin-off.
First CADI models (v.0) for Neurodegenerative Diseases
Psychiatric Diseases & Microbiota
Metabolic Disorders & Child Malnutrition
Autism Spectrum Disorders (ASD)
Indian National Program for child
Therapeutic Protocol for Low-Grade Inflammatory Diseases
Chronic Fatigue Syndrome/ ME
Gulf War Syndrome
GEMMA H2020 14,2 M€ project on
ASD - Microbota Interactions